Johannes MD - Roche Holding Head Devel

ROGN Stock  MXN 5,523  0.00  0.00%   

Insider

Johannes MD is Head Devel of Roche Holding AG
Age 66
Phone41 61 688 11 11
Webhttps://www.roche.com

Roche Holding Management Efficiency

The company has return on total asset (ROA) of 0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Roche Holding AG has accumulated 16.08 B in total debt with debt to equity ratio (D/E) of 63.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has a current ratio of 1.35, which is within standard range for the sector. Debt can assist Roche Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Roche Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Roche Holding AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Roche to invest in growth at high rates of return. When we think about Roche Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Sylvain GuerardMcEwen Mining
59
Hark ParkSamsung Electronics Co
59
Claudio LaporteGMxico Transportes SAB
N/A
Mihaela IancuMcEwen Mining
N/A
Kenneth PGeoMcEwen Mining
N/A
Jaeseung LeeSamsung Electronics Co
63
Antonio BrachoGMxico Transportes SAB
N/A
Ken JewRoss Stores
N/A
Paul MarosvariMicron Technology
53
Kyungwhoon CheunSamsung Electronics Co
N/A
HyunChong KimSamsung Electronics Co
N/A
JaeYong LeeSamsung Electronics Co
55
Isaac UnkindGMxico Transportes SAB
N/A
Scott AllenMicron Technology
55
Mary WrightMicron Technology
57
Miguel NeavesGMxico Transportes SAB
N/A
Carlos SierraGMxico Transportes SAB
N/A
Farhan AhmadMicron Technology
N/A
Rob BeardMicron Technology
N/A
Linnie HaynesworthMicron Technology
N/A
Stephen PGeoMcEwen Mining
64
Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HOLDINGS operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 82089 people. Roche Holding AG (ROGN) is traded on Mexican Exchange in Mexico and employs 103,613 people.

Management Performance

Roche Holding AG Leadership Team

Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Barbara Schadler, Head Communications
Claudia Bockstiegel, G Counsel
Bruno Eschli, Head Relations
Johannes MD, Head Devel
Thomas Schinecker, Chief Diagnostics
Cristina Wilbur, Member of the Executive Committee, Head Group Human Resources
William Anderson, Member of the Corporate Executive Committee, CEO Roche Pharmaceuticals
Alan Hippe, Member of the Corporate Executive Committee, CFO, Information Technology Officer
Severin Schwan, Chairman of the Corporate Executive Committee, CEO, Director
Pascale Schmidt, Chief Officer

Roche Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roche Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Roche Stock Analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.